Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Perspective
Nature Reviews Drug Discovery 3, 521–526 (1 June 2004) | doi:10.1038/nrd1418
Science, pharmacoeconomics and ethics in drug R&D: a sustainable future scenario?
Abstract
The costs associated with the development of new drugs have increased dramatically in recent years, and fewer truly innovative drugs are making their way to the market. The reversal of this trend has therefore become an urgent priority for the pharmaceutical industry. What are the factors that contribute to these costs, and to what extent can they be effectively controlled? Does the solution lie in new technologies? How is the industry dealing with these problems? And what are the ethical implications of these trends?
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
